Menu

I

Inflammatix

Verified

Visit Website Connect with Founders

Inflammatix develops a novel molecular diagnostics for acute infections and sepsis that work by reading the immune system. Healthcare Medical

About Inflammatix

Inflammatix builds in the healthcare category and is tracked by 100Xfounder for operating momentum, talent growth, and market execution.

What they do: Inflammatix develops a novel molecular diagnostics for acute infections and sepsis that work by reading the immune system. Healthcare Medical

Funding context: Khosla Ventures, $102M Series D in 2021

Recent milestones:

Inflammatix appears in the 100Xfounder startup directory import feed.

Why it Matters

Inflammatix matters because inflammatix develops a novel molecular diagnostics for acute infections and sepsis that work by reading the immune system. Healthcare Medical

Funding Snapshot

Total Funding: $102.00MLast Round: Series D Khosla Ventures, $102M Series D in 2021All Rounds: 1

Series D | Khosla Ventures, $102M Series D in 2021

Hiring Roles

This company is actively hiring.

Open Roles

Meet the Founders

Inflammatix Team

Inflammatix Team

Founder & CEO

Tech Stack

PythonGCPBigQueryReact

Last updated: April 17, 2026

Inflammatix intelligence brief

This profile combines core company context with linked founder, funding, and newsroom routes so readers can evaluate business momentum without switching across multiple tools. Use it as a baseline for comparing peers in the same industry and stage.

For deeper validation, pair this page with founder profile, company news coverage, and stage-based funding hubs to contextualize updates against wider market movement.

Related Companies

Alternatives in Healthcare with comparable market signals.

T

Thatch Team

View Company Compare Alternatives

T

Tempo Team

View Company Compare Alternatives

N

Neuralink Team

View Company Compare Alternatives

C

Cedar Team

View Company Compare Alternatives

SH

SWORD Health Team

View Company Compare Alternatives

SM

Scipher Medicine

Scipher Medicine Team

View Company Compare Alternatives

C

Calibrate Team

View Company Compare Alternatives

F

Forward Team

View Company Compare Alternatives

Discover Now

Newsroom and topic pages connected to Inflammatix.

Company News Hub Topic Hubs Funding News

No company-specific newsroom stories available yet.

Contextual Research Links

Jump to country, industry, stage, startup taxonomy, and newsroom routes tied to this company.

Company profile→Company news hub→Founder profile→United States startup directory→United States startup news→Startups in United States→Healthcare hub→Healthcare startup list→Series D startups→Series D startup list→

Want to get featured on 100Xfounder?

Want your company featured with founder details and funding visibility? Start here.

Contact Editorial Get Featured

FAQs About Inflammatix

Common questions people ask about this profile.

What is Inflammatix?

Inflammatix develops a novel molecular diagnostics for acute infections and sepsis that work by reading the immune system. Healthcare Medical

Who founded Inflammatix?

Inflammatix is associated with Inflammatix Team on 100Xfounder.

Where is Inflammatix located?

Inflammatix is listed in San Francisco Bay Area, California, USA.

What stage is Inflammatix in?

Inflammatix is currently mapped to Series D. Funding context: Khosla Ventures, $102M Series D in 2021

What is the latest funding round of Inflammatix?

Inflammatix's latest tracked round is Series D Khosla Ventures, $102M Series D in 2021. Total tracked rounds: 1.

Is Inflammatix hiring now?

Inflammatix hiring status: Open Roles.

What technologies does Inflammatix use?

Inflammatix is associated with Python, GCP, BigQuery, and React.

Is Inflammatix verified on 100Xfounder?

Yes. Inflammatix is currently marked verified on 100Xfounder as of April 17, 2026.

How can users connect with Inflammatix founders?

Users can open founder profiles, use listed company links, and track signal updates directly from the 100Xfounder directory.